课题基金 / 基金详情

Exploring ATR and PARP Inhibitors for Ovarian Cancer Management: An Innovative Approach

Exploring ATR and PARP Inhibitors for Ovarian Cancer Management: An Innovative Approach
探索 ATR 和 PARP 抑制剂用于卵巢癌治疗:一种创新方法
批准号:
494635
负责人:
Allen Christine J
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-09-01 至 2024-09-01

项目摘要

项目成果

Allen Christine J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In Canada, survival rates for advanced high-grade serous ovarian cancer (HGSOC), the most common type of OC, remain low. The approval of several PARP inhibitors (PARPi) over the last decade has changed the way that HGSOC is managed, resulting in unprecede
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Heat Activated Liposomal Delivery of Chemo and Molecular Therapy in Combination with Radiotherapy for Treatment of Breast Cancer Recurrence at the Chest Wall
  • 批准号:
    369901
  • 项目类别:
    Operating Grants
  • 资助金额:
    $33.44万
  • 财政年份:
    2017
  • 负责人:
    Allen Christine J
  • 依托单位:
Thermosensitive Liposome Formulation of Vinorelbine in Combination with MR-Guided High-Intensity Focused Ultrasound Mediated Hyperthermia: An Innovative Approach to Treatment of Rhabdomyosarcoma
  • 批准号:
    369851
  • 项目类别:
    Operating Grants
  • 资助金额:
    $25.08万
  • 财政年份:
    2017
  • 负责人:
    Allen Christine J
  • 依托单位:
Targeted Polymeric Nanotechnology for Multi-Modality Treatment of HER2 Positive Breast Cancer
  • 批准号:
    304886
  • 项目类别:
    Operating Grants
  • 资助金额:
    $35.9万
  • 财政年份:
    2014
  • 负责人:
    Allen Christine J
  • 依托单位:
Targeted Polymeric Nanotechnology for Multi-Modality Treatment of HER2 Positive Breast Cancer
  • 批准号:
    297889
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2013
  • 负责人:
    Allen Christine J
  • 依托单位:
海外基金